Women with a diagnosed fear of childbirth are at an increased risk of postpartum depression (PPD), according to a new study in BMJ Open.
Women with a diagnosed fear of childbirth are at an increased risk of postpartum depression (PPD), according to a new study in BMJ Open.
Researchers from the University of Eastern Finland, Kuopio University Hospital, the Finnish National Institute for Health and Welfare, Copenhagen University Hospital, the Nordic School of Public Health, and Emory University used data from three Finnish health registers for 2002-2010 and looked at all singleton births from that time (n= 511,422) to gauge the prevalence of PPD and the risk factors associated with it.
In total, 1439 of the 511,422 (0.3%) women experienced PPD. Women with a history of depression had a higher prevalence of PPD (1007 of 18,888, 5.3%) than women with no history of depression (431 of 511,422, 0.1%). In fact, after adjusting for variations, a history of depression was the strongest risk factor for PPD. Other strong risk factors for PPD include major congenital anomaly, nulliparity, cesarean birth, and fear of childbirth.
Among the 30% of women with PPD but no prior history of depression, PPD was associated with a fear of childbirth (adjusted odds rate [aOR] 2.71, 95% CI [confidence interval] 1.98 to 3.71); cesarean birth (aOR 1.38, 95% CI 1.08 to 1.77); preterm birth (aOR 1.65, 95% CI 1.08 to 2.56); and major congenital anomaly (aOR 1.67, 95% CI 1.15 to 2.42) when compared to women with no PPD and no history of depression.
Investigators concluded that a history of depression was the most important predisposing factor for PPD. Women with no history of depression were at an increased risk of PPD if certain adverse events occur during pregnancy. A physician-diagnosed fear of childbirth was the adverse event mostly likely to increase the risk of PPD in this population.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More